European Psychiatric Association guidance on treatment of cognitive impairment in schizophrenia.

ABSTRACT:

Background

Although cognitive impairment is a core symptom of schizophrenia related to poorer outcomes in different functional domains, it still remains a major therapeutic challenge. To date, no comprehensive treatment guidelines for cognitive impairment in schizophrenia are implemented.

Methods

The aim of the present guidance paper is to provide a comprehensive meta-review of the current available evidence-based treatments for cognitive impairment in schizophrenia. The guidance is structured into three sections: pharmacological treatment, psychosocial interventions, and somatic treatments.

Results

Based on the reviewed evidence, this European Psychiatric Association guidance recommends an appropriate pharmacological management as a fundamental starting point in the

SUBMITTER: Vita A 

PROVIDER: S-EPMC9532218 | biostudies-literature | 2022 Sep

REPOSITORIES: biostudies-literature